Table 2.
Response criteria | Response (N) |
---|---|
Morphological response (N = 25) | |
Partial remission | 7 (28%) |
Stable disease | 14 (56%) |
Progressive disease | 4 (16%) |
Biochemical response (CgA) (N = 25) | |
< 25% reduction | 12 (48%) |
25–50% reduction | 4 (16%) |
> 50% reduction | 7 (28%) |
Increase in CgA | 2 (8%) |
Symptomatic response (anti-hypertensive drugs) (N = 14) | |
Reduction of anti-HTN drugs | 6 (43%) |
No change | 8 (58%) |